Meet and network with the key influencers shaping the law, policy and proceedings of Paragraph IV litigation.

Each spring, leading pharmaceutical patent litigators for brand name and generic drug companies gather at the Paragraph IV Disputes conference to discuss, debate, and analyze the latest trends, judicial rulings and legislative developments affecting Hatch-Waxman litigation.  
As the industry prepares to address the fall out of global pharmaceutical patent losses of billions of dollars on the Hatch-Waxman landscape, the time for this conference has never been more relevant.

NEW for 2019!

A Fireside Chat with a Federal Circuit Judge


Honorable Kathleen M. O’Malley
United States Circuit Judge
United States Court of Appeals for the Federal Circuit

To see additional members of the judiciary who will be speaking at this year’s conference, download the conference announcement now.

Four New Advisory Board Members


Brian Anderson
Vice President & Assistant General Counsel
IP Litigation
Amy Hulina
SVP, Intellectual Property
Amneal Pharmaceuticals


Stephanie Donahue
Senior Director,
Patent Litigation
Jennifer Grant Moitoso
Vice President, Intellectual Property


Meet the Distinguished Members of ACI’s Hatch-Waxman Series Advisory Board >>

Agenda and speakers list will be available soon. Stay up-to-date by signing up to receive email announcements.

Register now and be part of the prestigious meeting of the minds.

Download the conference announcement and see what we’re planning!

Who you will meet

Patent attorneys and litigators (in-house & law firms) who represent:
  • Brand name pharmaceutical companies
  • Generic pharmaceutical companies
  • Biopharmaceutical companies

Event Contacts

For sponsorship opportunities please contact:
Wendy Tyler
Tel: 212-352-3220 ext. 5242
[email protected]

For media partnership opportunities please contact:
Linda Lam
Tel: 212-352-3220 ext. 5538
[email protected]

For questions about this year’s program/content, or information on how you can speak next year please contact:
Joseph Gallagher
Tel: 212.352.3220 ext. 5511
[email protected]

Connect With Us